Navigation Links
Triple Therapy Shows Better Improvement of Brain Functions

According to a study done on 179 stroke patients, it was found that triple drug therapy helped people suffer less brain damage when they had stroke. The three drug// a clot-preventing drug such as aspirin, an ACE inhibitor for blood pressure control, and a cholesterol-lowering statin. It is thought that these drugs work synergistically to reduce the amount of brain tissue that is damaged.

Dr. Magdy Selim, a neurologist at Harvard Medical School and co-director of the Stroke Center at Beth Israel Deaconess Hospital, in Boston said that 65% on triple therapy showed improvement of brain function. The researchers used imaging techniques and the National Institutes of Health Stroke Scale, which assesses 15 measures of brain damage, to determine the loss of function caused by the stroke. Patients taking all three drugs had higher scores on the stroke scale but they were discharged from the hospital a day sooner than those taking only aspirin and three days sooner than those taking none of the drugs.

Triple drug therapy patients showed lower risk of brain cell damage. Selim said that the three drugs may work together to improve blood flow thereby limiting the damage. But further research is necessary before the triple therapy could be recommended for everyone at high risk of stroke. Dr. Tanya N. Turan, an assistant professor of neurology at Emory University School of medicine, said that a big, randomized clinical trial is needed to show that the triple therapy protects against stroke damage.
'"/>




Page: 1

Related medicine news :

1. Severe Gum Disease Triples Heart Disease Risk
2. MMR Triple Vaccine Caught In the Eye of a Storm
3. Chinese Parents Warned Of Triple Health Scare
4. Analysis: Bowel Diseases Triples Infertility Risks In Women
5. World’s First Triple Transplant Performed by Australian Surgeon
6. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
7. Mother Of Triplets Gives Birth To Quadruplets
8. CHEK 2 Gene Mutation Triples Breast Cancer Risk
9. Triple-Monitoring System To Monitor Heart Viability During Surgery
10. Triple ARV Prophylaxis Reduces Viral Load in Breast Milk
11. Triple Negative Breast Cancers Seem to Affect the Young, Minority
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the ... dependent on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from ... in fatal overdoses in male populations.(1) , The proportion of women using illicit drugs ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health ... British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition ... Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol treatment ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination ... and concern over nerve agents and the deadly use of chemical weapons. Many questions ... and how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC ... North America, today announced it would be offering some it’s exclusive product line ... on crafting quality and unique baby clothing/feeding products, will team up with AMAZON ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology: